Abstract:Presently, the principal tools to combat malaria are restricted to killing the parasite in infected people and killing the mosquito vector to thwart transmission. While successful, these approaches are losing effectiveness in view of parasite resistance to drugs and mosquito resistance to insecticides. Clearly, new approaches to fight this deadly disease need to be developed. Recently, one such approach–engineering mosquito resident bacteria to secrete anti-parasite compounds–has proven in the laboratory to be highly effective. However, implementation of this strategy requires approval from regulators as it involves introduction of recombinant bacteria into the field. A frequent argument by regulators is that if something unexpectedly goes wrong after release, there must be a recall mechanism. This report addresses this concern. Previously we have shown that a Serratia bacterium isolated from a mosquito ovary is able to spread through mosquito populations and is amenable to be engineered to secrete anti-plasmodial compounds. We have introduced a plasmid into this bacterium that carries a fluorescent protein gene and show that when cultured in the laboratory, the plasmid is completely lost in about 130 bacterial generations. Importantly, when these bacteria were introduced into mosquitoes, the bacteria were transmitted from one generation to the next, but the plasmid was lost after three mosquito generations, rendering the bacteria non-recombinant (wild type). Furthermore, no evidence was obtained for horizontal transfer of the plasmid to other bacteria either in culture or in the mosquito. Prior to release, it is imperative to demonstrate that the genes that thwart parasite development in the mosquito are safe to the environment. This report describes a methodology to safely achieve this goal, utilizing transient expression from a plasmid that is gradually lost, returning the bacterium to wild type status.The intolerable burden of malaria demands the development of novel approaches to fight this deadly disease. Previously, the engineered symbiotic bacterium Serratia AS1 was shown in the laboratory to be able to spread through mosquito populations and render mosquitoes resistant to the parasite. However, a major concern of regulators for the release of such engineered bacteria into the field is that there is no option for "recall" in case something goes wrong. Here we show that Serratia AS1 loses plasmids as it replicates in mosquitoes and in culture, reverting to wild type. We also show that horizontal transfer of the plasmid from Serratia AS1 to other bacteria is extremely rare, as this was undetectable in the mosquito and in culture. Our results suggest that initial field trials can make use of this reversible system whereby released recombinant bacteria expressing anti-plasmodial compounds from a plasmid revert to wild type at a predictable rate.

PLASMODIUM FALCIPARUM TRANSMISSION‐BLOCKING PROTEINS SECRETED FROM BACTERIA IN THE MOSQUITO MIDGUT

Fighting malaria with engineered symbiotic bacteria from vector mosquitoes

Transgenic Anopheles mosquitoes expressing human PAI-1 impair malaria transmission

Studies of the Parasite-Midgut Interaction Reveal Plasmodium Proteins Important for Malaria Transmission to Mosquitoes

Combining transgenesis with paratransgenesis to fight malaria

A natural symbiotic bacterium drives mosquito refractoriness to Plasmodium infection via secretion of an antimalarial lipase

Self-limiting paratransgenesis

Driving mosquito refractoriness to Plasmodium falciparum with engineered symbiotic bacteria

Transmission-Blocking Strategies Against Malaria Parasites During Their Mosquito Stages

Outer membrane vesicles from a mosquito commensal mediate targeted killing of Plasmodium parasites via the phosphatidylcholine scavenging pathway

Functional Characterization and Comparison of Plasmodium Falciparum Proteins As Targets of Transmission-blocking Antibodies*

Genetic approaches to interfere with malaria transmission by vector mosquitoes

Transstadial and horizontal transfer of bacteria within a colony of Anopheles gambiae (Diptera: Culicidae) and oviposition response to bacteria-containing water

Plasmodium chitinases: revisiting a target of transmission‐blockade against malaria

Intra-specific diversity of Serratia marcescens in Anopheles mosquito midgut defines Plasmodium transmission capacity

Characterisation of the merozoite thrombospondin related anonymous protein (MTRAP) of Plasmodium berghei as a transmission-blocking antigen

The Anopheles gambiae adult midgut peritrophic matrix proteome

Plasmodium parasitophorous vacuole membrane protein Pfs16 promotes malaria transmission by silencing mosquito immunity

Killing of Plasmodium Sporozoites by Basic Amphipathic α-Helical Fusion Peptides

A Gut Symbiotic Bacterium Serratia marcescens Renders Mosquito Resistance to Plasmodium Infection Through Activation of Mosquito Immune Responses

Delftia tsuruhatensis TC1 symbiont suppresses malaria transmission by anopheline mosquitoes